Pentoxi-Mepha 400, Retardtabletten
7680493240140
CH-49324
Tabletten
Associated product:
Pentoxi-Mepha 400, Retardtabletten
1 / 3
google
Article details
- Package size
- 20
- Selling units
- 20
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
pentoxifyllinum
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
povidonum K 90
|
- | Substance | HNIDK |
|
ammonio methacrylatis copolymerum B
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
macrogolum 6000
|
- | Substance | HNIDK |
|
ethylis acrylatis et methylis methacrylatis polymerisatum 2:1
|
- | Substance | HNIDK |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 49324
- Drug name
- Pentoxi-Mepha 400, Retardtabletten
- Galenic form
- RETT
- ATC Code
- C04AD03
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- B
- First authorization
- 30/06/1988
- Authorization expiration date
- 31/12/2025
- IT Number
- 02.04.5.
- Domain
- Human medicine
Package details
- Description (FR)
- PENTOXI Mepha cpr ret 400 mg 20 pce
- Description (DE)
- PENTOXI Mepha Ret Tabl 400 mg 20 Stk
- Market withdrawal
- 31/12/2025
- Narcotic (BTM)
- No
Other package sizes (1)
PENTOXI Mepha cpr ret 400 mg 100 pce
100 TABL
GTIN: 7680493240225